This is the classic website, which will be retired eventually. Please visit the modernized instead.
Working… Menu

Study of Ifinatamab Deruxtecan (I-DXd) in Participants With Advanced Solid Malignant Tumors

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT04145622
Recruitment Status : Recruiting
First Posted : October 30, 2019
Last Update Posted : January 16, 2024
Information provided by (Responsible Party):
Daiichi Sankyo ( Daiichi Sankyo Co., Ltd. )

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : December 1, 2024
Estimated Study Completion Date : March 1, 2027